Freezing of Gait in Parkinson’s Disease

Freezing of gait is a Parkinson’s symptom where the feet suddenly stop responding, even though the person intends to keep walking. It tends to strike at doorways, turns, or narrow spaces, and while each episode may last only seconds, the fall risk it creates is significant, and its effect on independence over time is substantial.

According to Dr. Guruprasad Hosurkar, a neurologist in Bangalore specialising in Parkinson’s disease and movement disorders, “Freezing of gait is one of the most underreported symptoms in Parkinson’s patients, partly because it happens unpredictably and partly because patients often feel embarrassed to bring it up until after a fall has already occurred.”

Several factors contribute, and their relative weight differs from one patient to the next.

• Dopamine disruption: Walking requires the basal ganglia to sequence motor commands in a sustained rhythm, and when dopamine production drops in Parkinson’s, that sequencing breaks down, which is what produces the freeze response at the level of the nervous system.
• Medication timing: Many patients freeze almost exclusively during off periods, the intervals when dopamine levels fall between doses, and remain relatively mobile when medication is at its peak, which tells clinicians a great deal about where to intervene first.
• Environmental triggers: Doorways, turns, and transitions from standing to walking are the most reported situational triggers, and for some patients the anticipation of these environments alone is enough to increase freeze likelihood before they even reach them.
• Disease progression: As Parkinson’s advances, freeze episodes become longer and more frequent, correlating with broader motor deterioration rather than appearing independently, and they become significantly harder to manage in later disease stages.

A movement disorders treatment plan that specifically addresses freezing is essential, as standard Parkinson’s protocols do not always account for it adequately.

No single intervention resolves freezing consistently, and effective management typically requires several approaches working in combination.

• Medication optimisation: When freezing is predominantly off-state, adjusting the timing and dosage of dopaminergic medication is the first clinical step, and in many patients this alone produces a meaningful reduction in freeze frequency before any additional intervention is needed.
• Cueing strategies: Visual cues like floor markings and auditory cues like rhythmic beats redirect attention toward deliberate step initiation, and both have demonstrated consistent benefit in clinical practice, often producing immediate improvement in patients who haven’t responded adequately to medication adjustment alone.
• Physiotherapy: Structured gait training and treadmill-based exercises targeting stride length and movement rhythm reduce freeze frequency over time, with patients who engage consistently showing measurably better mobility outcomes than those on medication alone.
• DBS surgery: Where freezing is part of a broader pattern of medication-resistant motor symptoms, DBS surgery has demonstrated meaningful reduction in freeze frequency, particularly when evaluated before motor decline becomes advanced and surgical candidacy becomes harder to establish.

Reading about early warning signs of Parkinson’s disease provides useful context on how freezing fits within the broader trajectory of the condition before a specialist consultation.

Dr. Guruprasad Hosurkar has 22+ years in neurology and movement disorders, led India’s first Adaptive Closed-Loop DBS programme at KIMS Hospital, and was recognised as Inspiring Neurologist of the Year by the Economic Times in 2021, with patients reporting that symptoms were assessed thoroughly from the first visit and a structured management plan was in place rather than a generalised protocol.

References:

• Freezing of Gait in Parkinson’s Disease: Pathophysiology and Management — National Institute of Neurological Disorders and Stroke, NIH
• Gait Disorders in Parkinson’s Disease — PubMed, NCBI